Vertex Pharmaceuticals | Los Gastos Financieros De La Deuda



Interest Expense On Debt Cambio Fecha
AbbVie USD 610M 19M 2024-12
Acadia Pharmaceuticals 0 4.12M 2024-09
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 38.65M 325K 2025-03
Amgen USD 723M 24M 2025-03
Arrowhead Research USD 21.65M 7M 2024-12
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.86M 286K 2025-03
Bristol-Myers Squibb USD 494M 2M 2025-03
Gilead Sciences USD 260M 12M 2025-03
Incyte USD 660K 241K 2025-03
Insmed USD 19.8M 532K 2024-12
Ionis Pharmaceuticals USD 19M 16.41M 2025-03
J&J USD 128M 9M 2025-03
Merck USD 313M 15M 2025-03
Moderna USD 1000K 5M 2025-03
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12
Pfizer USD 654M 85M 2025-03
PTC Therapeutics USD 43.35M 1.24M 2024-12
Regeneron Pharmaceuticals USD 8.7M 1.8M 2025-03
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 213M 151M 2025-03
Sarepta Therapeutics USD 4.92M 86K 2024-09
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
United Therapeutics USD 6.1M 1.8M 2025-03
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



Vertex Pharmaceuticals Los Gastos Financieros De La Deuda - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.